Planned phase III pivotal trial of Vacc 4x in patients with HIV-1 infections
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Vacc-4x (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics; Registrational; Therapeutic Use
- Sponsors Bionor Holding
- 29 Jan 2018 According to a Bionor media release, Bionor Pharma changed its name to Bionor Holding.
- 16 Feb 2012 New trial record